We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+19.18%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.1B
AUM Growth
+$3.8B
Cap. Flow
+$2.09B
Cap. Flow %
14.81%
Top 10 Hldgs %
19.63%
Holding
2,124
New
675
Increased
443
Reduced
410
Closed
576

Top Buys

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$188M
2
AMZN icon
Amazon
AMZN
+$137M
3
ADBE icon
Adobe
ADBE
+$110M
4
EA
Electronic Arts
EA
+$110M
5
PFE icon
Pfizer
PFE
+$109M

Top Sells

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$131M
2
MSFT icon
Microsoft
MSFT
+$129M
3
V icon
Visa
V
+$119M
4
BKNG icon
Booking.com
BKNG
+$86M
5
HUM icon
Humana
HUM
+$82.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Technology 15.37%
3 Consumer Discretionary 10.44%
4 Industrials 8.59%
5 Financials 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FISV
26
Fiserv Inc
FISV
$27.9B
$120M 0.85%
1,354,485
+1,105,887
+445% +$91.2M
GPN icon
27
Global Payments
GPN
$22.8B
$116M 0.82%
852,698
+95,653
+13% +$11.6M
INTU icon
28
Intuit
INTU
$89B
$110M 0.78%
421,723
+306,242
+265% +$70.8M
ELV icon
29
Elevance Health
ELV
$85.5B
$107M 0.75%
371,175
+347,887
+1,494% +$101M
LRCX icon
30
Lam Research
LRCX
$390B
$104M 0.74%
5,821,060
+4,154,180
+249% +$69.3M
CSGP icon
31
CoStar Group
CSGP
$12.3B
$103M 0.73%
2,212,160
-55,490
-2% -$2.29M
BDX icon
32
Becton Dickinson
BDX
$48.7B
$102M 0.72%
418,066
-136,272
-25% -$32.2M
MA icon
33
Mastercard
MA
$493B
$102M 0.72%
432,090
+31,862
+8% +$6.85M
ISRG icon
34
Intuitive Surgical
ISRG
$134B
$102M 0.72%
534,042
+187,527
+54% +$33.3M
PGR icon
35
Progressive
PGR
$125B
$100M 0.71%
1,391,601
+137,549
+11% +$9.42M
MSCI icon
36
MSCI
MSCI
$40.9B
$100M 0.71%
503,784
+155,548
+45% +$27.1M
UHS icon
37
Universal Health Services
UHS
$10.5B
$99.4M 0.7%
742,994
+464,789
+167% +$61.2M
VZ icon
38
Verizon
VZ
$196B
$95.1M 0.67%
1,608,192
+1,535,329
+2,107% +$86.9M
PEP icon
39
PepsiCo
PEP
$190B
$95M 0.67%
775,020
+624,340
+414% +$71.1M
CTSH icon
40
Cognizant
CTSH
$26B
$93.3M 0.66%
1,287,515
+462,601
+56% +$32.4M
IDXX icon
41
Idexx Laboratories
IDXX
$46.2B
$90.3M 0.64%
404,041
+369,991
+1,087% +$76.4M
FOLD
42
DELISTED
Amicus Therapeutics
FOLD
$87.4M 0.62%
6,430,019
+1,113,735
+21% +$13.6M
IQV icon
43
IQVIA
IQV
$39.3B
$86M 0.61%
597,522
+247,784
+71% +$33M
SAGE
44
DELISTED
Sage Therapeutics
SAGE
$86M 0.61%
540,408
+53,704
+11% +$7.78M
A icon
45
Agilent Technologies
A
$41.2B
$84.8M 0.6%
1,055,080
+2,803
+0.3% +$213K
TMO icon
46
Thermo Fisher Scientific
TMO
$220B
$84.3M 0.6%
308,019
+294,820
+2,234% +$73.4M
ALXN
47
DELISTED
Alexion Pharmaceuticals
ALXN
$83.3M 0.59%
616,237
+193,470
+46% +$24.1M
V icon
48
Visa
V
$677B
$83.1M 0.59%
532,263
-824,439
-61% -$119M
COST icon
49
Costco
COST
$420B
$75.5M 0.53%
311,951
+144,254
+86% +$31.6M
SHW icon
50
Sherwin-Williams
SHW
$89.8B
$75.3M 0.53%
524,295
+253,830
+94% +$35.3M
1
2
3 4 5

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace North America held 2,124 positions worth $14.1B, up 37% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America deployed $2.09B of net new capital in Q1 2019, opening 675 new positions and adding to 443 existing holdings. Its largest new stake was bluebird bio: 36,744 shares worth $74.9M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Comcast, an estimated $131M trimmed.

  • Marshall Wace North America's largest Q1 2019 buy was bluebird bio: 36,744 shares worth $74.9M.
  • Marshall Wace North America added most to Fidelity National Information Services in Q1 2019, an estimated $188M increase.
  • Marshall Wace North America's biggest Q1 2019 reduction was Comcast, cutting an estimated $131M.
  • Marshall Wace North America fully exited Cboe Global Markets in Q1 2019, selling an estimated $67.7M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $14.1B portfolio in Q1 2019.
  • Marshall Wace North America opened 675 new positions and closed 576 in Q1 2019.
  • Marshall Wace North America's portfolio value rose 37% quarter-over-quarter to $14.1B.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.